← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
4e Therapeutics Inc.
Austin, TX
$7,126,294
Total funding
1
Grants
Funding over time
peak $2.2M · FY2019–23$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,126,294 · 1
By mechanism
U44$7,126,294 · 1
Investigators at 4e Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain$2,195,014
U44 · FY2023 · NS
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain$1,940,921
U44 · FY2022 · NS
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain$1,489,451
U44 · FY2019 · NS
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain$1,439,283
U44 · FY2021 · NS
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain$61,625
U44 · FY2020 · NS